SCHEMBL31376557

SCHEMBL31376557

Cc1ccc2cccc(N(C)[C@H]3CCCC[C@@H]3N(C)Cc3ccccn3)c2n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.35
SLC6A2 P23975 2/20 0.33
SLC6A4 P31645 2/20 0.33
SLC6A3 Q01959 2/20 0.33
DRD2 P14416 1/20 0.32
HTR2A P28223 1/20 0.32
SLC18A3 Q16572 1/20 0.32
MAPT P10636 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
LIN28A Q9H9Z2 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
CXCR4 P61073 3/20 0.32
HSD17B10 Q99714 1/20 0.32
SYK P43405 1/20 0.32
AURKB Q96GD4 1/20 0.32
INCENP Q9NQS7 1/20 0.32
ALDH1A1 P00352 1/20 0.32
METAP2 P50579 1/20 0.32
RAB9A P51151 1/20 0.31
MCHR1 Q99705 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25834398 0.89 METAP2 (0.34) SLC18A3CXCR4HSD17B10ALDH1A1METAP2
SCHEMBL25834397 0.89 METAP2 (0.34) SLC18A3CXCR4HSD17B10ALDH1A1METAP2
SCHEMBL31376570 0.89 METAP2 (0.34) SLC18A3CXCR4HSD17B10ALDH1A1METAP2
SCHEMBL31376581 0.84 HSD17B10 (0.31) HSD17B10METAP2
SCHEMBL25834386 0.83 METAP2 (0.44) TDP1HSD17B10METAP2RAB9AMCHR1
SCHEMBL25834475 0.83 METAP2 (0.44) TDP1HSD17B10METAP2RAB9AMCHR1
SCHEMBL25837289 0.83 METAP2 (0.44) TDP1HSD17B10METAP2RAB9AMCHR1
SCHEMBL31376551 0.81 PARP1 (0.34) SLC18A3CXCR4
SCHEMBL5556750 0.79 MAPT (0.49) TSHRDRD2HTR2ASLC18A3MAPT
SCHEMBL18991158 0.79 MAPT (0.49) TSHRDRD2HTR2ASLC18A3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250065315-A1 IRON COMPLEXES FOR ENANTIOSELECTIVE CIS DIHYDROXYLATION OF ALKENES Laboratory for Synthetic Chemistry and Chemical Biology Limited (CN) 2025-02-27 US disclosed
EP-4491270-A1 IRON COMPLEXES FOR ENANTIOSELECTIVE CIS DIHYDROXYLATION OF ALKENES The University of Hong Kong (HK) 2025-01-15 EP disclosed
CN-119306769-A Iron complexes for enantioselective cis dihydroxylation of olefins 香港大学 2025-01-14 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250065315-A1 IRON COMPLEXES FOR ENANTIOSELECTIVE CIS DIHYDROXYLATION OF ALKENES SQLE, NFE2L2, FECH TSHR 2082/4885SLC6A2 798/4885SLC6A4 1268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.